Earnings Call · Q4 FY2021·2022-02-11

Q4 21EPS -95.45%·Rev n/aQ3 21EPS -20.00%·Rev n/aQ2 21EPS -17.11%·Rev n/aQ1 21EPS -31.94%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Investor Relations or IR Host

Kevin Gorman — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Dr. Eiry Roberts — Chief Medical Officer

+7.4%1d on move date+9.4% vs SPY3d+8.7%5d+6.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access